6 September 2022
Information within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Fixed Income Investor Meetings
Benchmark (LSE: BMK), the aquaculture biotechnology company, announces that it has mandated DNB Markets to arrange a series of fixed income investor meetings commencing on 7 September 2022. A new 5-year senior unsecured floating rate green bond issue of up to NOK 925 million may follow, subject to inter alia market conditions.
In connection with the new bond issue, the company will offer a conditional buyback of its outstanding senior secured bonds with ticker "BHMH01" (ISIN NO0010858210) and maturity in June 2023, which will be contingent upon subscription in the new bond issue. Subject to completion of the potential new bond issue, Benchmark will call the remaining part of BHMH01 in whole.
Enquiries:
Benchmark Holdings plc |
Tel: 020 3696 0630 |
|
Trond Williksen, CEO Septima Maguire, CFO Ivonne Cantu, Investor Relations |
|
Numis (Broker and NOMAD) |
Tel: 020 7260 1000 |
James Black / Freddie Barnfield / Duncan Monteith |
|
MHP |
|
Katie Hunt/Reg Hoare |
Tel: 0203128 8742 |
About Benchmark
Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.
Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world. Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDMSCUPUBGBUPPGRA
==